INTRODUCTION
============

The evaluation for hypertrophic cardiomyopathy (HCM) relies principally on echocardiography and electrocardiography. Historically, the evolution of echocardiography has demonstrated the important morphological characteristics such as asymmetric pattern, systolic anterior motion of the mitral valve, obstructive form, and apical involvement.[@B1][@B2][@B3][@B4] Therefore, echocardiography is considered as the gold standard for identifying the clinical phenotype of HCM.[@B5] The electrocardiography also provides substantial information of HCM including mimic myocardial ischemia or infarction, and thereby creates diagnostic confusion.[@B6][@B7][@B8][@B9] However, most data were produced a long time ago and on the basis of relatively small population before the establishment of diagnostic consensus for HCM.[@B10][@B11] In addition, most data is about asymmetric HCM, while there are limited data on the apical HCM which was introduced later and was a relatively rare form in Western country.[@B5][@B6][@B12][@B13] We, therefore, investigated the morphological and electrical characteristics in a large Korean cohort, and they were compared among three HCM groups (asymmetric, apical, and mixed). It should be noted that we had already reported long-term survival between the two types of HCM.[@B14]

MATERIALS AND METHODS
=====================

Our study enrolled patients with HCM who underwent echocardiography at a large tertiary referral center in Korea, between March 1996 and November 2005. We excluded 93 patients that had no electrocardiogram or otherwise unreadable traces. Thus, a total of 864 patients were enrolled. The diagnosis of HCM was based on the presence of a hypertrophied left ventricle in the absence of other diseases capable of producing the degree of observed hypertrophy. The patients were divided into three types (apical, asymmetric, and mixed) as an involved myocardium. The diagnostic criteria for apical HCM included demonstration of asymmetric left ventricular (LV) hypertrophy, confined predominantly to the LV apex with an apical wall thickness ≥15 mm and a ratio of maximal apical to posterior wall thickness ≥1.5, based on two-dimensional echocardiography.[@B15] Asymmetric HCM was diagnosed in case of a septal-to-posterior (or posterior-to septal) wall thickness ratio of equal to or greater than 1.3.[@B2][@B16][@B17] Mixed type HCM was defined when a patient had a coexistent apical and asymmetric HCM. The 12-lead electrocardiograms for each of the eligible patients were obtained at the time of the initial evaluation for HCM. All electrocardiograms were retrospectively analyzed. The electrocardiographic parameters included heart rate, PR duration, corrected QRS duration, the presence of atrial fibrillation, the presence of pathologic Q wave, the presence of LV strain, the amplitude of T wave inversion in V4-6, and the amplitude of J-point elevation. LV strain was defined as ST-T segment vector shifted in direction opposite to the mean QRS complex.[@B18][@B19] Early repolarization patterns were stratified according to the degree of J-point elevation (\<0.1 mV, 0.1-0.2 mV, or \>0.2 mV) that was either notched or slurred in at least two consecutive anterior (V1-3), lateral (V4-6, I, aVL), or inferior (II, III, aVF) leads. A prolonged corrected QT interval was defined as at least 440 msec for men and at least 460 msec for women. A pathologic Q wave was defined as at least 25% or more of the height of the partner R wave and greater than 40 msec in width in at least two consecutive leads. The presence of atrial fibrillation was decided with the electrocardiography at the time of diagnosis of HCM. The electrocardiogram findings were compared among the three different HCM groups.

Categorical variables are presented as raw numbers and percentages, and were compared with the chi-square test or Fisher\'s exact test. Continuous variables are presented as mean±standard deviation and were compared by Kruskal Wallis test. A probability value \<0.05 was considered statistically significant. SPSS for Windows (12.0, SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. This study was approved by the Institutional Review Board at Asan Medical Center, Seoul, Korea.

RESULTS
=======

Demographic findings
--------------------

Baseline demographic and echocardiographic findings are summarized in [Table 1](#T1){ref-type="table"}, according to the type of HCM. Of 864 patients, 255 patients had apical HCM, 553 patients had asymmetric HCM, and 56 patients had mixed type HCM. The mean age was 55.4±14.2 years (from 12 to 92), and the patient with apical HCM was likely to be young compared to those with asymmetric HCM. The majority of patients were men. The proportion of patients with apical HCM increased in elder patients compared with stationary proportion of the patient with asymmetric and mixed type HCM ([Fig. 1](#F1){ref-type="fig"}). Beta blocker was prescribed in about a half of patients, while 42.4% of patients had no medication. The patients with verapamil were 16.1%.

Comparison of morphologic differences
-------------------------------------

30.4% of patients with asymmetric HCM had resting LV outflow tract obstruction. About three quarters of patients (75.8%) had left atrial enlargement, defined as equal to or more than 40 mm of anterior-posterior diameter. LV dilatations, considered as more than 55 mm of LV internal diameter in diastole, were observed in 6.1% of total patients. It was more frequent in patients with apical HCM (12.2% in apical HCM, 3.1% in asymmetric HCM, and 8.9% in mixed type HCM, *p*\<0.001, by Kruskal Wallis test). The prevalence of LV dilatation was increased with age (6.1% in total). Mean ejection fraction was within normal range, and LV systolic dysfunction, defined as equal to or less than 50%, was observed in 2.4% of patients. There were no difference of incidence according to the type of HCM. Deceleration time in patient with asymmetric HCM was longer than those with apical HCM. Prolonged deceleration time, considered as more than 220 msec, were prevalent in patient with asymmetric HCM (41.5% in total, 29.5% in apical HCM, 48.0% in asymmetric HCM, and 33.3% in mixed type HCM, *p*\<0.001, by Kruskal Wallis test).

Comparisons of ECG findings
---------------------------

Electrocardiographic findings are summarized in [Table 2](#T2){ref-type="table"}. Patients with asymmetric HCM were likely to have long PR interval and long QRS duration. Wide QRS (17.7% vs. 4.7%, *p*\<0.001) and PR prolongation (14.8% vs. 6.8%, *p*=0.003) were more prevalent in patients with asymmetric HCM compared to those with apical HCM. The prevalence of atrial fibrillation at the diagnosis was 8.1% (11.0% in apical HCM, 7.1% in asymmetric HCM, *p*=0.17), and it increased in elder patients.

Early repolarization, considered as more than 0.1 mV of J-point elevation, was found in 32.3% of anterior leads, 9.5% of inferior leads, and 2.2% of lateral leads. Significant J-point elevations, defined as more than 0.2 mV, were found in 12.7% (anterior leads), 2.9% (inferior leads), and 0.8% (lateral leads) of patients.

Repolarization abnormalities
----------------------------

Patients with apical HCM were likely to have LV strain and deep negative T wave ([Figs. 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Giant negative T wave, defined as a negative T wave with depth ≥1 mV, was observed in 15.0% of total patients (32.2% in apical HCM, 6.2% in asymmetric HCM, 25% in mixed type HCM). In patients with apical HCM, there was no significant correlation between the thickness of the apical wall and the amplitude of T wave inversion (r=-0.005, *p*=0.71) ([Fig. 4](#F4){ref-type="fig"}). Abnormal findings of electrocardiography were included the pattern of LV strain, longer than 480 msec of corrected QT interval, longer than 120 msec of PR interval, the presence of atrial fibrillation, the presence of LV strain, and more than 0.2 mV of the elevation of J-point. Their frequencies of abnormal findings according to the type of HCM are shown in [Fig. 2](#F2){ref-type="fig"}. LV strain and QT prolongation were frequently observed in patients with HCM (68.9% and 52.5%, respectively).

DISCUSSION
==========

Major findings
--------------

In 864 Korean cohort of patients with HCM, significant electrical as well as morphological abnormalities were found. The major findings on electrical abnormalities were as follows; 1) more than half of patients had a repolarization abnormality presenting LV strain and QT prolongation, 2) giant negative T wave were observed in 15.0% of total patients, mostly patients with apical HCM, 3) the prevalence of wide QRS and PR prolongation were not infrequent, especially in patients with asymmetric HCM.

Echocardiographic evaluation revealed that the prevalence of apical HCM was increased with age until seventh decade, and substantial portion of patients had left atrial enlargement (75.8%) and deceleration time prolongation (41.5%), suggesting diastolic dysfunction.

Comparison with previous studies
--------------------------------

HCM is a complex and relatively common genetic cardiac disorder.[@B20] Although the majority of patients are asymptomatic, that is allowed to delayed diagnosis, some present with severe symptoms and some may even die suddenly because of fatal ventricular arrhythmia. LV obstruction by asymmetrical septal hypertrophy is the first discovered and a very specific finding in HCM.[@B21][@B22] Therefore, most morphological and electrical observations for HCM have been based on the population with these findings.[@B6][@B7][@B9][@B11][@B23][@B24] However, the evolution of echocardiography demonstrated heterogeneous clinical phenotypes such as non-obstruction form and apical hypertrophy,[@B1][@B4] and established the diagnosis of HCM.[@B5][@B11][@B25] However, there is a little data about morphological and electrical characteristics since the consensus for diagnosis and management of HCM were established. Especially, the differences of asymmetric HCM and apical HCM are hardly known.

In the demographic results, the patients with apical HCM were likely to be old compared to those with asymmetric HCM, and their prevalence was increased with age ([Fig. 1](#F1){ref-type="fig"}). It is quite possible that almost all patients with apical HCM had no obstruction of the LV outflow tract and relatively benign prognosis. Although it was possible to be under-diagnosed in women of such a tertiary referral population, the majority of patients were men, in consistance with previous reports, especially in patients with apical HCM.[@B15][@B26] In the echocardiographic results, substantial portion of patients were likely to have diastolic dysfunction, and it was consistent with previous data.[@B27][@B28] In other word, systolic dysfunction suggesting burned out phase was rare at the time of diagnosis.[@B17][@B29] With age, the prevalence of LV dilatation was increased, while those of LV obstruction was decreased. Although these findings were derived from cross-sectional observation, it was supported by the previous reports for progressive LV remodeling in patients with HCM.[@B29][@B30][@B31]

There are some uncertainties over medical treatment of the patients with HCM. While 40% of patients had no medication and near half of patients were prescribed beta blocker in our routine practice, it was highly dependent on individual situations such as symptom, compliance, and physician\'s discretion, which are not described in the present study. It is one of the limitations of the present study. However, the initiation and maintenance of pharmacologic treatment are largely subjected to patient\'s compliance and physician\'s discretion. Symptom and response for medication are highly variable in terms of magnitude and duration of benefit. Therefore, it is difficult to objectively categorize patient\'s symptom and medication.

Repolarization abnormalities in HCM
-----------------------------------

Various electrocardiographic abnormalities were found in our study. They included LV strain, QT prolongation, QRS prolongation, PR prolongation, atrial fibrillation, and J point elevation more than 0.2 mV in anterior leads, and pathologic Q wave.

More than half of patients showed repolarization abnormality like LV strain (68.9%) and QT prolongation (52.5%). Reversal of the sequence of depolarization secondary to severe and localized LV hypertrophy was considered as mechanism of LV strain.[@B32] LV strain was defined as ST-T segment vector shifted in direction opposite to the mean QRS complex in the present study, and it is similar to T wave inversion in other studies. It was reported that T wave inversion in the lateral leads is seen commonly in HCM. In the asymptomatic young athletes with HCM, 62% exhibited T wave inversion.[@B33] Similarly, in HCM patients with a positive genetic test, 54% demonstrate T wave inversion.[@B34] Our study confirmed that T wave inversion was common in patients with HCM and demonstrated that its prevalence was different as the type of HCM. Giant negative T wave was considered as classic electrocardiographic finding of HCM. However, it seemed not to be sensitive parameter of HCM, since only 14.8% of our patients showed giant negative T wave. No significant relationship between apical wall thickness and the degree of T wave inversion was found in the present study, in agreement with previous report.[@B35]

Other ECG abnormalities in patients with HCM
--------------------------------------------

Recently, early repolarization has received attention for association with sudden cardiac death.[@B36] Quantitative analysis showed that significant J wave elevation, more than 2 mV, was more frequently observed in patients with HCM (2.9% in inferior leads, 0.8% in lateral leads) than that previously reported in general population (0.3% in inferior leads, 0.3% in lateral leads).[@B36] Clinical significance of repolarization abnormality in patients with HCM should be clarified in further longitudinal study. The prevalence of atrial fibrillation in our population was 8.1% (11.0% in apical, 7.1% in asymmetric, 5.4% in mixed type, mean age 55.4 years), much higher than that in Eastern general populations including Korean (0.7%, mean age 54.6 years),[@B37] Japanese (1.6%, mean age 72.1 years),[@B38] Hong Kong (1.3%, mean age 71 years)[@B39] as well as in Western general population (0.95%, mean age 71 years).[@B40] And it is comparable with that in Western HCM population (5% at the time of diagnosis, mean age 55 years).[@B41] Atrial fibrillation in patients with HCM was challenging and associated with substantial risk for mortality and morbidity.[@B41] In our results, only persistent atrial fibrillation might be detected, indicating an another limitation of our study: the prevalence of atrial fibrillation could be higher, about three times in a previous study, if paroxysmal atrial fibrillation was included.[@B41]

Study limitation
----------------

Our results had several limitations. First, we could not evaluate genetic analysis or magnetic resonance imaging for diagnostic test. Second, this study was based on the database of a tertiary referral center, and a community-based study is warranted to avoid referral bias.

Conclusion
----------

This large Korean cohort of HCM including apical type demonstrated that repolarization abnormalities including early repolarization and QT prolongation as well as LV strain were significantly observed. T wave inversion was not appropriate for screening of HCM and not correlated with apical wall thickness.
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![Electrocardiographic abnormalities according to the type of hypertrophy. ^\*^Advanced electrical abnormalities such as QT prolongation, QRS widening, PR prolongation, and pathologic Q wave were more prevalent in patients with asymmetric hypertrophy. LV, left ventricle; QTc, corrected QT duration ≥480 msec; QRS, QRS duration ≥120 msec; PR, PR interval ≥200 msec; Q wave, pathologic Q wave; anterior J, J point in anterior leads ≥0.1 mV; inferior J, J point in inferior leads ≥0.1 mV; lateral J, J point in lateral leads ≥0.1 mV; AF, atrial fibrillation.](ymj-56-1515-g002){#F2}
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![Correlation between apical wall thickness and the amplitude of T wave inversion in patients with apical hypertrophy. No significant correlation was observed.](ymj-56-1515-g004){#F4}

###### Demographic and Echocardiographic Characteristics
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                              Total (n=864)   Apical HCM (n=255)   Asymmetric HCM (n=553)   Mixed type HCM (n=56)   *p* value
  --------------------------- --------------- -------------------- ------------------------ ----------------------- -----------
  Age (yrs)                   55.4±14.2       59.9±11.8            52.9±14.9                59.3±11.6               \<0.001
  Men                         595 (68.9)      182 (71.4)           369 (66.7)               44 (78.6)               0.11
  LVOT obstruction            163 (20.4)      0 (0)                159 (30.4)               4 (7.4)                 \<0.001
  IVSs (mm)                   22.3±6.3        16.7±2.8             25.2±5.7                 20.3±4.7                \<0.001
  IVSd (mm)                   18.1±6.4        11.7±2.4             21.2±5.4                 15.9±4.6                \<0.001
  Left atrium (cm)            44.2±6.8        44.2±6.9             44.2±6.8                 43.3±6.6                0.45
  LVPWs (mm)                  17.4±3.6        17.3±2.8             17.4±3.9                 17.2±3.8                0.82
  LVPWd (mm)                  11.3±2.7        11.5±2.1             11.3±2.9                 10.9±2.8                0.26
  LVIDs (mm)                  26.6±5.9        28.6±4.9             25.6±6.1                 27.5±5.0                \<0.001
  LVIDd (mm)                  46.0±6.2        49.3±5.3             44.4±6.0                 47.9±5.5                \<0.001
  End systolic volume (mL)    24.8±10.3       23.5±9.5             25.5±10.7                23.8±8.6                0.03
  End diastolic volume (mL)   69.9±23.8       66.8±23.3            71.7±24.1                65.8±21.6               0.01
  IVSd/LVPWd                  1.7±0.6         1.0±0.1              2.0±0.5                  1.5±0.3                 \<0.001
  Ejection fraction (%)       64.5±6.6        64.7±6.2             64.5±6.9                 63.6±5.6                0.57
  E wave (m/sec)              63.9±18.4       61.9±15.2            65.1±19.8                61.6±16.2               0.12
  A wave (m/sec)              65.5±21.5       65.0±17.8            66.4±23.1                59.2±20.1               0.05
  Deceleration time (msec)    222.3±68.8      206.1±52.5           231.5±74.5               207.4±61.0              \<0.001
  Medications                                                                                                       
   Beta blocker               406 (47.7)      104 (40.8)           281 (50.8)               21 (47.7)               0.03
   Verapamil                  137 (16.1)      32 (12.5)            101 (18.3)               4 (9.1)                 \-
   Amiodarone                 55 (6.5)        10 (3.9)             43 (7.8)                 2 (4.5)                 \-
   Sotalol                    8 (0.9)         2 (0.8)              3 (0.5)                  3 (6.8)                 \-
   Propafenone                1 (0.1)         1 (0.4)              0 (0)                    0 (0)                   \-
   Flecainide                 3 (0.4)         1 (0.4)              2 (0.4)                  0 (0)                   \-
   No medication              361 (42.4)      125 (49.0)           214 (38.7)               22 (50.0)               0.01

HCM, hypertrophic cardiomyopathy; LVOT, left ventricular outflow tract; IVSd, interventricular septum end diastole; IVSs, interventricular septum end systole; LVPWs, left ventricular posterior wall end systole; LVPWd, left ventricular posterior wall end diastole; LVIDs, left ventricular internal diameter end systole; LVIDd, left ventricular internal diameter end diastole.

###### Electrocardiographic Findings
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                                        Total (n=864)   Apical HCM (n=255)   Asymmetric HCM (n=553)   Mixed type HCM (n=56)   *p* value
  ------------------------------------- --------------- -------------------- ------------------------ ----------------------- -----------
  Heart rate (per mins)                 67.5±14.7       68.0±14.9            67.5±14.6                65.1±14.5               0.29
  PR interval (msec)                    166.7±31.2      160.0±31.6           170.4±30.1               160.6±34.7              \<0.001
  QRS duration (msec)                   102.5±19.3      96.8±13.6            105.4±21.3               99.3±12.8               \<0.001
  Corrected QT interval (msec)          439.5±27.5      438.1±24.1           439.9±29.2               441.2±24.6              0.77
  Atrial fibrillation                   70 (8.1)        28 (11.0)            39 (7.1)                 3 (5.4)                 0.14
  J point elevation in anterior leads                                                                                         0.001
   \<0.1 mV                             585 (67.7)      192 (75.3)           348 (62.9)               45 (80.4)               
   0.1-0.2 mV                           169 (19.6)      37 (14.5)            123 (22.2)               9 (16.1)                
   \>0.2 mV                             110 (12.7)      26 (10.2)            82 (14.8)                2 (3.6)                 
  J point elevation in inferior leads                                                                                         0.28
   \<0.1 mV                             782 (90.5)      230 (90.2)           498 (90.1)               54 (96.4)               
   0.1-0.2 mV                           57 (6.6)        20 (7.8)             35 (6.3)                 2 (3.6)                 
   \>0.2 mV                             25 (2.9)        5 (2.0)              20 (3.6)                 0 (0)                   
  J point elevation in lateral leads                                                                                          0.29
   \<0.1 mV                             845 (97.8)      251 (98.4)           538 (97.3)               56 (100)                
   0.1-0.2 mV                           12 (1.4)        1 (0.4)              11 (2.0)                 0 (0)                   
   \>0.2 mV                             7 (0.8)         3 (1.2)              4 (0.7)                  0 (0)                   
  Amplitude of negative T wave (mV)     0.6±0.5         0.8±0.5              0.5±0.4                  0.7±0.5                 \<0.001

HCM, hypertrophic cardiomyopathy.
